Omeros Corp (LTS:0KBU) Stock News, Headlines & Updates
Omeros Corp Stock News from GuruFocus
- 1
Oct 24, 2024
FDA Grants Rare Pediatric Disease Designation to Omeros' MASP-3 Inhibitor Zaltenibart for Treatment of C3 Glomerulopathy
Business Wire • 8:00am
Oct 03, 2024
OMER Stock Falls 5.35% Amid Mixed Institutional Ratings
GuruFocus News • 2:54pm
Oct 01, 2024
Omeros (OMER) Shares Drop 5.04% Amid Financial Struggles
GuruFocus Research • 2:56pm
Aug 08, 2024
Omeros Corp (OMER) Q2 2024 Earnings Call Transcript Highlights: Financial Cushion and Clinical Progress Amid Rising Losses
GuruFocus Research • 1:01pm
Q2 2024 Omeros Corp Earnings Call Transcript
GuruFocus Research • 12:17pm
Aug 07, 2024
Omeros Corporation Reports Second Quarter 2024 Financial Results
Business Wire • 4:00pm
Aug 05, 2024
Omeros Corporation to Announce Second Quarter Financial Results on August 7, 2024
Business Wire • 4:00pm
- 1
Show
Entries
Headlines
Total 0- 1
No recent news